Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-956
Closed -$225K 123
2020
Q2
$225K Sell
956
-145
-13% -$33.1K 0.09% 112
2020
Q1
$223K Hold
1,101
0.1% 104
2019
Q4
$265K Sell
1,101
-173
-14% -$38.1K 0.1% 105
2019
Q3
$247K Buy
+1,274
New +$245K 0.09% 107
2019
Q1
Sell
-1,843
Closed -$217K 142
2018
Q4
$217K Sell
1,843
-43
-2% -$8.39K 0.12% 110
2018
Q3
$240K Buy
1,886
+357
+23% +$70.4K 0.13% 105
2018
Q2
$282K Sell
1,529
-449
-23% -$79.4K 0.12% 104
2018
Q1
$333K Buy
+1,978
New +$363K 0.15% 97

Other funds holding AMGN

Bridgeworth's AMGN Position: Q3 2020 in Review

Bridgeworth sold out of Amgen (AMGN) in Q3 2020, closing a stake of 956 shares — an estimated $225K sold.

Bridgeworth first reported a position in AMGN in Q1 2018 and held it in 8 quarters. The position peaked at $333K in Q1 2018. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Bridgeworth reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Bridgeworth sold 956 Amgen shares in Q3 2020, an estimated $225K.
  • Bridgeworth first reported a position in Amgen in Q1 2018 and held it in 8 quarters.
  • Bridgeworth's Amgen position peaked at $333K in Q1 2018.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Bridgeworth's 13F filing for Q3 2020, filed 13 Nov 2020.